Vasopressin, prolactin and growth hormone in Alzheimer's disease: their evaluation after metoclopramide stimulation

Giorgio Lipponi, Giancarlo Cadeddu, Roberto Antonicelli, Maurizio Compagnucci, Liana Spazzafumo, Ferdinando Foschi, Remo Gaetti

Research output: Contribution to journalArticle

Abstract

Recent studies have shown that there is a relationship between an alteration of central neurotransmitters and the modification of some biohumoral parameters in Alzheimer's Disease (AD). In this study the authors evaluated, after metoclopramide (MTC) stimulation, the concentration curve of vasopressin (AVP), prolactin (PRL) and growth hormone (HGH) in the plasma of 34 subjects (20 males and 14 females, mean age 70.5±6.9 years; 17 were AD patients, the others constituted the control group). MTC increased AVP serum concentration in healthy (P

Original languageEnglish
Pages (from-to)269-278
Number of pages10
JournalArchives of Gerontology and Geriatrics
Volume10
Issue number3
DOIs
Publication statusPublished - 1990

Keywords

  • Alzheimer's disease
  • Growth hormone
  • Metoclopramide
  • Prolactin
  • Vasopressin

ASJC Scopus subject areas

  • Ageing
  • Medicine(all)

Fingerprint Dive into the research topics of 'Vasopressin, prolactin and growth hormone in Alzheimer's disease: their evaluation after metoclopramide stimulation'. Together they form a unique fingerprint.

  • Cite this